You have 9 free searches left this month | for more free features.

Nephritis, Interstitial

Showing 1 - 25 of 1,444

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Interstitial Nephritis, Drug-Induced Interstitial Nephritis Trial in Paris (in vitro Allergological test Allergological

Not yet recruiting
  • Acute Interstitial Nephritis
  • Drug-Induced Interstitial Nephritis
  • in vitro Allergological test Allergological skin tests
  • Paris, France
    Nephrology department, Tenon hospital - APHP
Jun 29, 2022

Acute Kidney Injury, Acute Interstitial Nephritis, Kidney Diseases Trial in New Haven

Recruiting
  • Acute Kidney Injury
  • +2 more
    • New Haven, Connecticut
    • +1 more
    Jan 25, 2023

    Urine Alkalinazation on Urinary Inflammatory Markers in

    Completed
    • Cystinuria
    • +3 more
    • Potassium citrate
    • Paris, Ile-de-France, France
      Eurpean Georges Pompidou Hospital
    Mar 21, 2022

    Acute Tubulo-Interstitial Nephritis Trial in Herning (Prednisone)

    Recruiting
    • Acute Tubulo-Interstitial Nephritis
    • Herning, Denmark
      Godstrup Hospital
    Dec 29, 2020

    Salt and Potassium Diet of Patients Followed in Nephrology

    Completed
    • Nephropathy, Chronic Tubulointerstitial
    • Salt and potassium Diet
    • Lyon, France
      Hôpital Edouard Herriot - Service de néphrologie - HTA - Dialyse
    Sep 16, 2020

    Acute Interstitial Nephritis Trial in Rochester (Omalizumab, Prednisone)

    Withdrawn
    • Acute Interstitial Nephritis
    • Rochester, Minnesota
      Mayo Clinic
    Dec 4, 2018

    Dynamic Imaging of Variation in Lupus Nephritis

    Completed
    • Lupus Nephritis
    • MRI
    • Aurora, Colorado
    • +5 more
    Oct 1, 2021

    Anti-ficolin-3 Antibodies in Lupus Nephritis

    Completed
    • Systemic Lupus Erythematosus Nephritis
    • Biological analysis
    • La Tronche, France
      JOUVE
    Sep 27, 2021

    Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance Study -

    Not yet recruiting
    • Biliary Tract Cancer
      • (no location specified)
      Apr 26, 2023

      Precision Medicine in LN: A Multicenter Proof-of-concept Study

      Recruiting
      • Lupus Nephritis
      • Systemic Lupus Erythematosus
        • Vigo, Pontevedra, Spain
          IRIDIS-VIGO Group (Investigation in Rheumatology and Immune-Medi
        Apr 28, 2022

        Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance

        Not yet recruiting
        • Carcinoma, Non-Small-Cell Lung
          • (no location specified)
          Apr 21, 2023

          Lupus Nephritis Trial in Worldwide (Anifrolumab, Placebo)

          Completed
          • Lupus Nephritis
          • Anifrolumab
          • Placebo
          • Glendale, Arizona
          • +79 more
          Oct 28, 2021

          Predict Adverse Events by Covid-19 Nephritis

          Completed
          • Covid-19
            • Göttingen, Germany
              University Medical Center Goettingen
            Apr 27, 2021

            Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, ANCA-Associated Glomerulonephritis Trial in Chongqing

            Recruiting
            • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
            • ANCA-Associated Glomerulonephritis
            • Chongqing, Chongqing, China
              Children's Hospital of Chongqing Medical University
            Jul 23, 2023

            Renal Biopsy Unexplained Elevated Serum Creatinine

            Active, not recruiting
            • Renal Impairment
            • renal biopsy
            • Assiut, Egypt
              Assiut University Hospital
            Jul 19, 2022

            Lupus Nephritis, Remission, Safety Issues Trial in Nanjing (Methylprednisolone Injectable Suspension, Belimumab Injection,

            Recruiting
            • Lupus Nephritis
            • +2 more
            • Methylprednisolone Injectable Suspension
            • +2 more
            • Nanjing, Jiangsu, China
              Jiong Zhang
            May 8, 2023

            Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,

            Recruiting
            • Lupus Nephritis
            • +2 more
            • KYV-101 anti-CD19 CAR-T cell therapy
            • Standard lymphodepletion regimen
            • Denver, Colorado
            • +1 more
            Jul 7, 2023

            IL17 in Systemic Lupus Erythematosus Patients: Association With

            Not yet recruiting
            • Systemic Lupus Erythematosus
            • Serum level of IL-17
            • Sohag, Egypt
              Sohag University Hospital
            Sep 12, 2021

            AntiDFS70 Lupus Nephritis

            Recruiting
            • Systemic Lupus Erythematosus
            • anti dfs70 antibodies
            • Sohag, Egypt
              Sohag university Hospital
            Nov 6, 2023

            Lupus Nephritis Trial in China (efgartigimod IV, Placebo)

            Recruiting
            • Lupus Nephritis
            • efgartigimod IV
            • Placebo
            • Beijing, China
            • +9 more
            Apr 11, 2023

            Lupus Nephritis Trial (Felzartamab)

            Not yet recruiting
            • Lupus Nephritis
            • (no location specified)
            Sep 26, 2023

            Lymphocyte Subsets of Peripheral Blood in Nonmyopathic

            Recruiting
            • Dermatomyositis
              • Jinan, Shandong, China
                Yanfeng Hou
              Nov 19, 2023

              Lupus Nephritis Trial in Philippines, Taiwan (ANX009)

              Recruiting
              • Lupus Nephritis
              • ANX009
              • Angeles City, Philippines
              • +6 more
              Mar 10, 2023

              Lupus Nephritis Trial in China (Telitacicept 240 mg, Telitacicept 160 mg, Placebo)

              Not yet recruiting
              • Lupus Nephritis
              • Telitacicept 240 mg
              • +2 more
              • Hefei, Anhui, China
              • +44 more
              Jan 11, 2023

              Interstitial Lung Disease Trial in Ankara (Upper extremity high-intensity interval aerobic exercise training, Control Group)

              Not yet recruiting
              • Interstitial Lung Disease
              • Upper extremity high-intensity interval aerobic exercise training
              • Control Group
              • Ankara, Çankaya, Turkey
                Gazi University, Faculty of Health Sciences, Department of Physi
              Jun 14, 2023